A study at Memorial Sloan-Kettering Cancer Center developed a large scale genetic analysis of multiple prostate cancer samples that is providing exciting new insight into the disease and may lead to more effective treatment strategies. In addition, the freely available genetic and clinical outcome data obtained in the study represents a valuable public resource for the cancer research community.
According to study leader, all findings clarify the role of several known cancer pathways in prostate cancer, implicate several new ones, and provide a blueprint for clinical development of pathway inhibitors.
The good news is all the data obtained in the study was made available through an easily accessible web-based application and are published online by Cell Press on June 24th in the journal Cancer Cell.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...